Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

OBJECTIVE: Many patients with major depressive disorder (MDD) suffer from residual symptoms without achieving remission. However, pharmacologic options for residual symptoms of MDD have been limited. This study aimed to investigate benefit of aripiprazole augmentation in the treatment of residual sy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Psychopharmacol Neurosci
Autori principali: Shin, Cheolmin, Pae, Chi-Un, Kwak, Kyung Phil, Jeon, Sang Won, Jeong, Hyun-Ghang, Kim, Jong-Woo, Lee, Youn Jung, Patkar, Ashwin A., Han, Changsu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean College of Neuropsychopharmacology 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8077065/
https://ncbi.nlm.nih.gov/pubmed/33888653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.2.243
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi